Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Teladoc Health, Inc. (TDOC)

Bliss Kelly — President, U.S. Group Health
Jul 1, 2026
Sale
Shares
2,500
Price
$9.00
Total Value
$22.50K
Shares Held After
87,378
% of Holdings
2.8%

American Well Corp (AMWL)

Gotlib Phyllis — President, International
Jul 1, 2026
Sale
Shares
6,677
Price
$9.33
Total Value
$62.30K
Shares Held After
152,754
% of Holdings
4.2%

American Well Corp (AMWL)

HIRSCHHORN MARK — Chief Financial Officer
Jul 1, 2026
Sale
Shares
4,299
Price
$9.33
Total Value
$40.11K
Shares Held After
238,939
% of Holdings
1.8%

American Well Corp (AMWL)

Zamansky Dmitry — Chief Product & Tech. Officer
Jul 1, 2026
Sale
Shares
8,460
Price
$9.33
Total Value
$78.93K
Shares Held After
232,620
% of Holdings
3.5%

American Well Corp (AMWL)

McNeice Paul Francis — Chief Accounting Officer
Jul 1, 2026
Sale
Shares
653
Price
$9.33
Total Value
$6.09K
Shares Held After
9,851
% of Holdings
6.2%
Jul 1, 2026
Sale
Shares
25,000
Price
$24.00
Total Value
$600.00K
Shares Held After
1,103,816
% of Holdings
2.2%
Jul 1, 2026
Purchase
Shares
3,057
Price
$1.93
Total Value
$5.90K
Shares Held After
15,492
% of Holdings
19.7%
Jun 30, 2026
Sale
Shares
200
Price
$6.30
Total Value
$1.26K
Shares Held After
3,581,293
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
19,650
Price
$6.02
Total Value
$118.32K
Shares Held After
3,581,493
% of Holdings
0.5%
Jun 30, 2026
Sale
Shares
45,419
Price
$6.14
Total Value
$279.05K
Shares Held After
3,601,143
% of Holdings
1.2%

Tectonic Therapeutic, Inc. (TECX)

McNamara Peter — Chief Scientific Officer
Jun 30, 2026
Sale
Shares
172
Price
$35.00
Total Value
$6.02K
Shares Held After
55,285
% of Holdings
0.3%
Jun 30, 2026
Sale
Shares
1,900
Price
$34.84
Total Value
$66.20K
Shares Held After
1,047,205
% of Holdings
0.2%
Jun 30, 2026
Sale
Shares
23,100
Price
$34.26
Total Value
$791.48K
Shares Held After
1,049,105
% of Holdings
2.2%
Jun 30, 2026
Sale
Shares
1,000
Price
$9.00
Total Value
$9.00K
Shares Held After
0
% of Holdings
100.0%

Monte Rosa Therapeutics, Inc. (GLUE)

Janku Filip — Chief Medical Officer
Jun 30, 2026
Sale
Shares
5,407
Price
$24.50
Total Value
$132.47K
Shares Held After
60,612
% of Holdings
8.2%
Jun 30, 2026
Sale
Shares
240
Price
$549.27
Total Value
$131.82K
Shares Held After
40,513
% of Holdings
0.6%
Jun 30, 2026
Sale
Shares
14
Price
$546.60
Total Value
$7.65K
Shares Held After
40,753
% of Holdings
0.0%
Jun 30, 2026
Sale
Shares
66
Price
$545.96
Total Value
$36.03K
Shares Held After
40,767
% of Holdings
0.2%
Jun 30, 2026
Sale
Shares
440
Price
$543.30
Total Value
$239.05K
Shares Held After
40,833
% of Holdings
1.1%
Jun 30, 2026
Sale
Shares
1,081
Price
$542.62
Total Value
$586.57K
Shares Held After
41,273
% of Holdings
2.6%
Jun 30, 2026
Sale
Shares
2,499
Price
$541.60
Total Value
$1.35M
Shares Held After
42,354
% of Holdings
5.6%
Jun 30, 2026
Sale
Shares
2,235
Price
$540.76
Total Value
$1.21M
Shares Held After
44,853
% of Holdings
4.7%
Jun 30, 2026
Sale
Shares
1,309
Price
$539.93
Total Value
$706.77K
Shares Held After
47,088
% of Holdings
2.7%
Jun 30, 2026
Sale
Shares
988
Price
$538.51
Total Value
$532.04K
Shares Held After
48,397
% of Holdings
2.0%
Jun 30, 2026
Sale
Shares
518
Price
$537.75
Total Value
$278.55K
Shares Held After
49,385
% of Holdings
1.0%
Jun 30, 2026
Sale
Shares
110
Price
$536.28
Total Value
$58.99K
Shares Held After
49,903
% of Holdings
0.2%

Processa Pharmaceuticals, Inc. (PCSA)

Guy Wendy — Chief Administrative Officer
Jun 30, 2026
Purchase
Shares
2,436
Price
$1.93
Total Value
$4.70K
Shares Held After
14,394
% of Holdings
16.9%

Rapport Therapeutics, Inc. (RAPP)

Gault Cheryl — Chief Operating Officer
Jun 30, 2026
Sale
Shares
1,000
Price
$43.15
Total Value
$43.15K
Shares Held After
149,914
% of Holdings
0.7%

Rapport Therapeutics, Inc. (RAPP)

Gault Cheryl — Chief Operating Officer
Jun 30, 2026
Sale
Shares
3,308
Price
$42.17
Total Value
$139.51K
Shares Held After
150,914
% of Holdings
2.1%

Rapport Therapeutics, Inc. (RAPP)

Gault Cheryl — Chief Operating Officer
Jun 30, 2026
Sale
Shares
3,792
Price
$41.39
Total Value
$156.96K
Shares Held After
154,222
% of Holdings
2.4%

Rapport Therapeutics, Inc. (RAPP)

Gault Cheryl — Chief Operating Officer
Jun 30, 2026
Sale
Shares
1,900
Price
$40.09
Total Value
$76.17K
Shares Held After
158,014
% of Holdings
1.2%
Jun 30, 2026
Sale
Shares
135,590
Price
$28.97
Total Value
$3.93M
Shares Held After
7,751,570
% of Holdings
1.7%
Jun 30, 2026
Sale
Shares
488,654
Price
$28.35
Total Value
$13.85M
Shares Held After
7,887,160
% of Holdings
5.8%
Jun 30, 2026
Purchase
Shares
2,531
Price
$1.93
Total Value
$4.88K
Shares Held After
21,729
% of Holdings
11.6%

Processa Pharmaceuticals, Inc. (PCSA)

SKIBSTED RUSSELL — Chief Financial Officer
Jun 30, 2026
Purchase
Shares
3,277
Price
$1.93
Total Value
$6.32K
Shares Held After
16,689
% of Holdings
19.6%

BioAge Labs, Inc. (BIOA)

Barton Shane — Principal Accounting Officer
Jun 30, 2026
Sale
Shares
20,216
Price
$25.19
Total Value
$509.18K
Shares Held After
0
% of Holdings
100.0%

Zai Lab Ltd (ZLAB)

Du Ying — Director
Jun 30, 2026
Sale
Shares
7,026
Price
$18.53
Total Value
$130.22K
Shares Held After
1,203,784
% of Holdings
0.6%

Processa Pharmaceuticals, Inc. (PCSA)

Lin Patrick — Chief Business - Strategy Off
Jun 30, 2026
Purchase
Shares
2,106
Price
$1.93
Total Value
$4.06K
Shares Held After
13,113
% of Holdings
16.1%

X4 Pharmaceuticals, Inc (XFOR)

KIRSKE DAVID — Chief Financial Officer
Jun 30, 2026
Sale
Shares
8,543
Price
$4.26
Total Value
$36.43K
Shares Held After
167,750
% of Holdings
4.8%
Jun 30, 2026
Purchase
Shares
50,000
Price
$18.32
Total Value
$916.00K
Shares Held After
3,186,576
% of Holdings
1.6%
Jun 30, 2026
Purchase
Shares
12,500
Price
$20.00
Total Value
$250.00K
Shares Held After
3,688,424
% of Holdings
0.3%

Alpha Tau Medical Ltd. (DRTS)

Levy Raphi — Chief Financial Officer
Jun 30, 2026
Sale
Shares
20,000
Price
$12.00
Total Value
$240.04K
Shares Held After
90,180
% of Holdings
18.2%
Jun 30, 2026
Sale
Shares
200,000
Price
$35.45
Total Value
$7.09M
Shares Held After
1,748,403
% of Holdings
10.3%
Jun 30, 2026
Sale
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Jun 30, 2026
Sale
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%

Roivant Sciences Ltd. (ROIV)

QVT Financial LP — Director by Deputization
Jun 30, 2026
Sale
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Jun 30, 2026
Sale
Shares
619
Price
$91.40
Total Value
$56.58K
Shares Held After
40,411
% of Holdings
1.5%
Jun 30, 2026
Sale
Shares
17,000
Price
$26.82
Total Value
$455.90K
Shares Held After
614,321
% of Holdings
2.7%
Jun 30, 2026
Sale
Shares
58,000
Price
$25.94
Total Value
$1.50M
Shares Held After
631,321
% of Holdings
8.4%
Jun 29, 2026
Sale
Shares
350
Price
$6.00
Total Value
$2.10K
Shares Held After
3,601,143
% of Holdings
0.0%
Version: v26.5.2